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ABSTRACT 
Objective: The aim of the present study was to select excipients in an oral solid dosage form with a dry extract of round-leaved wintergreen (Pyrola 
rotundifolia L.) by using asymmetric, rotatable composite plan of the second-order (uniform plan No. 17). 
Methods: The tablets were prepared by using a direct compression method. The most important pharmaceutical factors selected were considered 
in more details at developing the optimal composition and technology of the studied tablets of the round-leaved wintergreen extract. Each one was 
studied at five levels using asymmetric, rotatable composite plan of the second order. 
Results: Increasing amounts of PROSOLV® EASYtab SP and croscarmellose sodium in the powder mass, its flowability decreases, and increasing 
amounts of Tablettose® 80 improves flowability. Increasing the amount of Tablettose® 80 in the tablets composition leads to improved uniformity. 
The strength of the tablets increased with increasing amounts of Neusilin® US 2 at different combinations of levels of the other three factors. When 
studying the effect of the amounts of croscarmellose sodium on the disintegration of tablets, it was found that the best disintegration values were 
obtained in the study of croscarmellose sodium at the upper level. 
Conclusion: Oral solid dosage form with dry extract of round-leaved wintergreen was successfully prepared by the direct compression method. The 
optimal composition of tablets was determined by the regression analysis.  
Keywords: Pyrola rotundifolia L., Round-leaved wintergreen, Dry extract, Tablets, Mathematical planning of the experiment 




Kidney diseases are a very important medical and social problem, 
associated with widespread prevalence and significant risks of renal 
failure, disability and death as their consequences. 
About 10% of the world population suffers from chronic kidney 
diseases [1]. The chronic kidney failure is one of the biggest 
challenges of modern nephrology since it is caused by the 
progressive course of chronic kidney disease [2]. 
Because of the development of chronic kidney failure, the number of 
patients who need the substitutive renal therapy (hemodialysis, 
peritoneal dialysis, kidney transplantation) increases annually. Such 
methods are extremely expensive and their usage is a huge 
economic problem all around the world. 
Therefore, it is very important to prevent, diagnose and adequately 
treat all kidney diseases [1]. 
Nowadays, searching for plants with a long history of usage, minor 
side effects and high tolerability, regardless of the age of patients, as 
well as the development of effective medications on their basis for 
prevention and treatment of urinary system disorders are the 
objects of interest in our society [3]. 
Pyrola rotundifolia L. has a wide range of pharmacological activities: 
antimicrobial, diuretic, anti-inflammatory, and nephroprotective 
ones. Pyrola rotundifolia L., commonly known as round-leaved 
wintergreen, belonging to family Ericaceae. 
The technology of getting the dry extract of round-leaved 
wintergreen was developed. The complex of the pharmacological 
action of the dry extract has been confirmed, which allows using 
it for the treatment and prevention of the urinary system 
diseases. 
In previous studies, the effect of 27 excipients on the technological 
characteristics of round-leaved wintergreen extract tablets was studied.  
Four of the best excipients have been identified, Neusilin® US 2, 
PROSOLV® EASYtab SP, sodium croscarmellose, Tablettose® 80, 
which were selected for further investigation and determination of 
optimal composition using asymmetric, rotatable composite plan of 
the second order. 
The purpose of the study was to select excipients in oral solid dosage 
form with dry extract of round-leaved wintergreen (Pyrola 
rotundifolia L.) by using a symmetric, rotatable composite plan of the 
second-order (uniform plan No. 17). 
When planning an experiment, mathematical methods were used not 
only at the stage of processing the results but also at the very first stage 
of experimentation, called the creation of an experiment plan [4, 5]. 
MATERIALS AND METHODS 
Plant materials 
Round-leaved wintergreen was collected in Northern Ukraine, Kovel 
district, Volyn region (N 51 °46'80.47" E 25 °01'37.12"), during a mass 
flowering period in 2016. The raw material was authenticated by a 
senior researcher, Dr. Andriy Kotov (Ukrainian Scientific 
Pharmacopoeial Center for Quality of Medicines, Kharkiv, Ukraine). A 
voucher specimen no. 0118 is kept at the Department of Standardization 
of Herbal Drugs and Herbal Drug Preparation, Ukrainian Scientific 
Pharmacopoeial Center for Quality of Medicines, Kharkiv, Ukraine. 
We have studied the following excipients in the development of the 
optimal composition of tablets: dry extract of round-leaved 
wintergreen, Neusilin® US 2(Fuji Chemical Industry Co., LTD, Japan), 
PROSOLV® EASYtab SP (JRS Parma LTD, Germany), croscarmellose 
sodium SOLUTAB® A (Roquette, France), Tablettose®80 (Meggle 
LTD, Germany), VIVAPUR®112 (JRS Parma LTD, Germany), 
magnesium stearate (Tablube®MgSt micronized vegetable). 
Four excipients were studied using asymmetric, rotatable composite 
plan of the second-order (uniform plan No. 17). The length of the 
star arm for this plan is 2.0. The star point was found by multiplying 
the variation interval by the star arm value. These values were 
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added to the baseline, getting the upper star point («+α») and 
subtracted to obtain a lower star point («-α») [4]. 
When developing the optimal composition of the round-leaved 
wintergreen extract tablets, each of the four excipients was studied 
at five levels (table 1) [6, 7]. 
 
Table 1: Factors studied in the development of the optimal composition of the round-leaved wintergreen extract tablets 
Factor Level of factor 
Lower star point «-α» Lower «-» Basic «0» Upper «+» Upper star point «+α» 
х1–quantity of Neusilin® US2, % 2 3 4 5 6 
х2–quantity of PROSOLV® EASYtab SP, % 6 9 12 15 18 
х3–quantity of croscarmellose sodium, % 1 3 5 7 9 
х4–quantity of Tablettose® 80, % 1 4 7 10 13 
 
Neusilin® US 2 is a synthetic amorphous form of magnesium 
aluminometa silicate and is widely accepted as a multifunctional 
excipient that improves the quality of pharmaceuticals [8-10]. 
PROSOLV® EASYtab is a multi-functional co-processed excipient that 
produces similar functionalities to the physical mixture from its 
individual components while improving process-related quality 
attributes and minimizing undesirable properties that may be 
associated with the physical mixture [11].  
PROSOLV® EASYtab SP is a complex excipients that combines MCC, 
silicon colloidal dioxide, sodium starch glycolate, sodium stearine 
fumarate [12]. 
Sodium croscarmellose was studied as a disintegrant to reduce the 
disintegration time of tablets [13]. 
Tablettose® 80 was specially developed for direct compression, 
combining good flowability and compressibility of various lactose 
fractions [14].  
Magnesium stearate was studied as a lubricant, 1% of a tablet 
weight was added to each batch [15, 16]. 
VIVAPUR®112 is excipients, which brought tablets to a specific 
average weight of 0.6 g [17]. 
Pre-compression evaluation 
In order to develop the optimal composition of the round-leaved 
wintergreen extract tablets by the direct compression method, the 
following technological operations were performed: sieving, 
weighing, mixing, powdering, and pressing. Model mixtures were 
prepared as follows: all the necessary components were weighed, 
sieved, a weighed active ingredient was added to VIVAPUR® 112–
dry extract of round-leaved wintergreen, stirred, PROSOLV® 
EASYtab SP, Tablettose® 80 was added to the resulting mixture, 
stirred up, Neusilin® US 2 was added, mixed to uniformity, 
croscarmellose sodium was added and dusted with a lubricant. The 
powder mixture was mixed and its pharmacological properties were 
studied-flowability, bulk density and tapped density. After that, they 
pressed tablets on a tablet machine with a punch diameter of 12 mm 
and a mass of 0.6 g and studied the tableting process. 
Bulk density 
Bulk density was determined by pouring the powder into a 
graduated cylinder. The volume and weight of the mixture was 
determined. Bulk density is the ratio of the total weight of the 
powder to the bulk volume of the powder. 
Tapped density 
Tapped density is the ratio of the general mass of the powder to the 
tapped volume of the powder. The tapped density was measured by 
tapping the powder mixture for 500 times [18].  
Flowability 
The fluidity was determined using the stationary funnel method. The 
powder mixture (±100 g) was poured through a funnel. The time of 
flow of the powder mixture through the funnel was used to calculate 
the flowability of the powder mixture [19]. 
Tableting process 
When pressing tablets of tablets of dry extract of round-leaved 
wintergreen, the tableting process was evaluated on a scale from 
one to five. The pressing process was evaluated by the following 
criteria: matrix backfill, expelling effort, sticking of the tablet mass to 
the press. The following evaluation criteria were used. 
5 points-the matrix is filled up homogeneously, the tablet mass and 
tablets do not stick to the press, the tablets are expelled without 
much effort. 
4 points-the matrix is filled up almost homogeneously, punches have 
a slight residue, but the tablet mass and tablets do not stick to 
punches, tablets are expelled with the application of some effort. 
3 points-the matrix is filled up heterogeneously, the tablet mass and 
tablets slightly stick to the punches, the tablets are expelled with 
much effort. 
2 points-the matrix is not filled up with tablet mass, tablets stick to 
the press and are damage [20]. 
Preparation and evaluation of tablets 
The powder mixture was stirred up prior to tabletting, part of the 
powder mixture was pressed on a laboratory tablet machine with a 
punch diameter of 12 mm and a weight of 0.6 g, the obtained tablets 
were examined for appearance and uniformity of dosage units. The 
remaining powder mixture was pressed on a tablet press at a pressure of 
50 N using a punch diameter of 12 mm and a tablet weight of 0.6 g. The 
obtained tablets were tested for compliance with pharmaco-
technological quality indicators, such as: disintegration, strength, 
abrasion. 
Tablets appearance  
Tablet's appearance was determined visually in daylight, viewing 
against a white background. 
Uniformity of weight 
Twenty tablets were weighed separately and the average weight was 
calculated, the deviation should not exceed±5% for tablets weighing 
0.6 g [21]. 
The tablets hardness 
The tablet's hardness was determined on a tablet analyzer ERWEKA 
TBH 220 D. Measurements were performed on 10 tablets. For 
tablets with a diameter of 12 mm, the resistance to crushing must be 
at least 50 N. 
The friability test 
Tests were performed to determine the tablets resistance to 
mechanical impact, or friability. In determining the friability, they 
used a drum unit with one blade. With a tablet weight of 0.6 g, 10 
tablets are weighed before and immediately after abrasion. Friability 
is expressed as a weight loss calculated as a percentage. The tablets 
withstood the test if they were not chipped or cracked and the 
friability value did not exceed 1% [19, 21]. 
The disintegration time 
Tablet disintegration tests were performed using an ERWEKA ZT 
502 tablet and capsule disintegration device, maintaining the 
temperature 37±2 °C. Disintegration of uncoated tablets should take 
no more than 15 min. 
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Statistical analysis 
To process the experimental data obtained using the method of 
mathematical planning of the experiment used by Statistica 6.0. The 
level of significance was set at *p<0.05 for all statistical analyses. 
RESULTS AND DISCUSSION 
The experiment planning matrix and the test results for tablets made 
of round-leaved wintergreen extract are shown in table 2. 
The second order model for four factors is as follows [22, 23]: 
У = b0x0+b1x1+b2x2+b3x3+b4x4+b12x1x2+b13x1x3+b14x1x4+b23x2х3+ 
b24х2х4++b34х3х4+b11х12+b22х22+b33х32+b44х42 
The test results were interpreted based on the analysis of regression 
equations. The statistical significance of the coefficients and 
adequacy of the models were checked using the F-criterion [24]. The 
regression equations were adequate when Ftest.<Ftabl [4]. Effect of the 
studied factors was determined by the values and operators of the 
regression coefficients. 
Effect of the studied factors on the bulk density of powders 
containing round-leaved wintergreen extract is described by the 
following regression equation:  
y1 = 0,531–0,0088x1+0,009x3+0,01x4+0,0032 х12+0,003 х22 
According to the regression equation, with increasing amounts of 
croscarmellose sodium and Tablettose®80, the bulk density of 
powders containing round-leaved wintergreen extract increases, 
and decreases with increasing Neusilin® US 2. 
The regression equation for the tapped density of powders 
containing round-leaved wintergreen extract has the following form:  
y2 = 0,6748–0,0089x1+0,0091x3+0,01x4 
The studied factors affect the tapped density the same way as for the 
bulk density. The tapped density increases when the amount of 
croscarmellose sodium and Tablettose® 80 increases, and decreases 
with increasing Neusilin® US 2. 
The relationship between the studied factors and flowability of the 
powders containing round-leaved wintergreen extract is described 
by the following regression equation:  
y3 = 31,35+1,3x1+0,4 x2+0,23x3–0,76x4+0,14x1x4+0,76x2x3–0,27x2x4–
0,34x3x4+0,9x12+0,34x22–0,13 x42 
When the coefficients of pair interactions are significant, it is 
advisable to interpret the regression equation using graphs. 
For significant linear factors, the regression equations were 
interpreted using one-factor graphical drawings. In the regression 
equation, the factor x1 has the most significant effect. The effect of 
Neusilin® US 2 amount on flowability of powder mixtures containing 
round-leaved wintergreen extract is shown in fig. 1. 
The fig. shows that when studying the amounts of PROSOLV® 
EASYtab SP (x2), croscarmellose sodium (x3) and Tablettose® 80 (x4) 
at the basic level (line 1)-the flowability of the powder mixtures was 
the highest, the amounts of Neusilin® US 2 (x1) at the bottom and 
basic levels had the most evident effect on flowability, with the 
Neusilin® US 2 on the upper and upper star points being studied, the 
response was significantly impaired. According to the regression 
equation, with increasing amounts of PROSOLV® EASYtab SP and 
croscarmellose sodium in the powder mass, its flowability 
decreases, and increasing amounts of Tablettose® 80 improves 
flowability. 
The effect of quantitative factors on the appearance of tablets of 
round-leaved wintergreen extract is described by the following 
regression equation:  
y4 = 4,93–0,08x2–0,13x3–0,13 x1x4+0,19x2x3–0,14x12–
0,20x22+0,08x32–0,08x42 
The effect of the most significant factor x3 on the appearance of 
tablets of round-leaved wintergreen extract is shown in fig. 2 
 
Table 2: The experiment planning matrix and the test results for tablets made of round-leaved wintergreen extract 
Butch number х1 х2 х3 х4 у1 у2 у3 у4 у5 у6 у7 у8 у9 
1 2 3 4 5 6 7 8 10 11 12 13 14 15 
1 1 1 1 1 0,553 0,677 33,81 5 5,0 0,94 200 0,0662 9 
2 -1 1 1 1 0,568 0,700 30,62 5 5,0 1,85 200 0,1327 10 
3 1 -1 1 1 0,553 0,677 32,48 5 4,5 1,75 199 0,0331 9 
4 -1 -1 1 1 0,568 0,700 29,29 5 5,0 1,45 199 0,0993 9 
5 1 1 -1 1 0,538 0,700 31,19 5 4,5 1,77 199 0,0663 12 
6 -1 1 -1 1 0,553 0,677 29,67 5 5,0 1,22 199 0,0995 12 
7 1 -1 -1 1 0,525 0,677 33,81 5 5,0 1,87 200 0,0663 14 
8 -1 -1 -1 1 0,538 0,677 30,24 5 5,0 1,36 196 0,0663 11 
9 1 1 1 -1 0,512 0,677 35,62 5 5,0 1,70 184 0,0994 9 
10 -1 1 1 -1 0,553 0,700 33,33 5 4,0 2,57 172 0,1321 8 
11 1 -1 1 -1 0,538 0,656 33,00 5 4,0 2,09 199 0,0331 10 
12 -1 -1 1 -1 0,538 0,700 30,95 5 4,5 2,30 200 0,0664 10 
13 1 1 -1 -1 0,512 0,656 32,67 5 4,0 1,58 200 0,0331 14 
14 -1 1 -1 -1 0,538 0,656 29,81 5 4,0 0,85 200 0,0663 15 
15 1 -1 -1 -1 0,525 0,636 32,86 5 5,0 1,46 200 0,0662 15 
16 -1 -1 -1 -1 0,525 0,677 30,86 5 4,5 0,78 200 0,0662 14 
17 2 0 0 0 0,525 0,636 33,57 5 4,0 1,58 200 0,0663 10 
18 -2 0 0 0 0,568 0,677 28,33 5 4,0 0,90 170 0,0995 9 
19 0 2 0 0 0,553 0,656 33,57 5 3,5 0,85 191 0,0332 10 
20 0 -2 0 0 0,538 0,677 30,38 5 4,0 1,31 136 0,1326 9 
21 0 0 2 0 0,568 0,700 29,67 5 3,5 1,64 199 0,0996 11 
22 0 0 -2 0 0,525 0,656 30,95 5 5,0 1,35 199 0,0995 23 
23 0 0 0 2 0,568 0,700 27,52 5 3,5 0,67 194 0,0660 10 
24 0 0 0 -2 0,512 0,636 32,62 5 5,0 1,94 200 0,0659 12 
25 0 0 0 0 0,525 0,677 31,57 5 5,0 1,46 178 0,0662 12 
26 0 0 0 0 0,525 0,677 31,43 5 4,5 1,58 181 0,0663 13 
27 0 0 0 0 0,538 0,700 31,10 5 5,0 1,20 184 0,0995 13 
28 0 0 0 0 0,525 0,677 30,95 5 5,0 1,46 183 0,0668 13 
29 0 0 0 0 0,525 0,656 31,52 5 5,0 1,94 176 0,0664 13 
30 0 0 0 0 0,538 0,677 31,48 5 5,0 1,49 199 0,0662 13 
31 00 0 0 0 0,538 0,656 31,24 5 5,0 1,78 180 0,0990 13 
Notes: y1–bulk density, g/cm3; y2–tapped density, g/cm3, y3–flowability, s/100g; y4–tablets appearance, scores, y5–tableting process, scores; y6–
uniformity of weight, %, y7–the tablets hardness, N; y8–the friability test, %, y9–the disintegration time, min. 
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Fig. 1: The effect of Neusilin® US 2 amount (x1) on flowability of powder mixtures containing round-leaved wintergreen extract 
 
 
Fig. 2: The effect of croscarmellose sodium (x3) on appearance of tablets of round-leaved wintergreen extract 
 
The best appearance values were provided by the amount of 
excipients, Neusilin® US 2 (x1), PROSOLV® EASYtab SP (x2), 
Tablettose® 80 (x4) at the basic level (line 1). The change in the 
amounts of croscarmellose sodium (x3) at the basic level affected the 
appearance as follows: the lower star point (5.5 points), the lower 
level (5.1 points), the basic level (4.93 points), the upper level (4, 88 
points) and the upper star point (4.99 points). It is experimentally 
established that the investigated excipients in the composition of 
round-leaved wintergreen extract within the studied intervals do 
not affect the compression process. All series of experiments on the 
process of pressing tablets of round-leaved wintergreen got 5 points. 
The relationship between the factors studied and the uniformity of 
tablet weight is described by the following regression equation:  
y6 = 1,56+0,18x3–0,15 х4–0,26 x1x3–0,26x3x4 
The effect of the most significant factor, the amount of croscarmellose 
sodium (x3) on the uniformity of the tablets dosage is shown in fig. 3 
 
 
Fig. 3: The effect of croscarmellose sodium (x3) on uniformity of dosage units of tablets of round-leaved wintergreen extract 
Budniak et al. 
Int J App Pharm, Vol 11, Issue 6, 2019, 210-216 
214 
Stable uniformity of dosage units in the range from 1.2% to 1.92% is 
provided by the amount of Neusilin® US 2 (x1), PROSOLV® EASYtab 
SP (x2), Tablettose® 80 (x4) when tested at the basic level (line 1), 
with an increase in the amount of croscarmellose sodium (x3) leads 
to a deterioration in uniformity of tablets of round-leaved 
wintergreen extract. Increasing the amount of Tablettose® 80 in the 
tablets composition leads to improved uniformity. 
The relationship between the factors studied and the tablets 
hardness of round-leaved wintergreen extract is described by the 
following regression equation:  
y7 = 183,16+3,13х1–3,09 x22+5,78 х32+5,28 х42 
The effect of the amount of Neusilin® US 2 (factor x1) on the tablets 
hardness of round-leaved wintergreen extract is shown in fig. 4 
 
 
Fig. 4: The effect of the amount of Neusilin® US 2 (factor x1) on the tablets hardness of round-leaved wintergreen extract 
 
At this stage of the study, they obtained tablets of round-leaved 
wintergreen extract with high resistance to crushing in all series of 
experiments. 
The strength of the tablets increased with increasing amounts of 
Neusilin® US 2 (x1) at different combinations of levels of the other 
three factors. The highest rates of tablet strength were observed 
when studying the amounts of PROSOLV® EASYtab SP (x2), 
croscarmellose sodium (x3), Tablettose® 80 (x4) at the "upper star 
points" (lines 3 and 5), the lowest when stabilized at the basic level 
(line 1). 
The relationship between the quantitative factors and friability of 
tablets of round-leaved wintergreen extract is described by the 
following regression equation:  
y8 = 0,076–0,0138x1–0,01 х1х3+0,01 х2х3 
 
 
Fig. 5: The effect of the amount of Neusilin® US 2 (factor x1) on the friability of tablets of round-leaved wintergreen extract 
 
Fig. 5 shows that the highest friability of the tablets is observed 
when studying the factors x1, x2, x3 at the upper star points and the 
amounts of Neusilin® US 2 (x1) at the lower star point, then the 
friability of tablets was 0.18%; it should be noted that when 
increasing the amount of Neusilin® US 2 at this level, the friability of 
tablets improved significantly, and when studying the quantities of 
Neusilin® US 2 (x1) at the upper star point it was 0.05%. 
The same value of the friability index was obtained when studying 
quantities of PROSOLV® EASYtab SP (x2), croscarmellose sodium 
(x3), Tablettose® 80 (x4) at the basic level (line 1), and quantities of 
Neusilin® US 2 (x1) at the upper star point. It should be noted that 
reducing the amounts of x2, x3, x4 from the upper star point (line 3) 
to the basic level (line 1) significantly improves the friability rate. 
The relationship between the factors studied and the disintegration of 
the studied tablets is described by the following regression equation:  
y9 = 12,87+0,21 x1–2,38 x3–0,54 x4–0,31x1x2–0,19 x1x3+0,19 
х2х4+0,56 х3х4–0,91 х12–0,91 х22+0,96 х32–0,54 х42 
The effect of the most significant factor (x3) on disintegration of the 
studied tablets is shown in fig. 6 
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Fig. 6: The effect of croscarmellose sodium (x3) on the disintegration of tablets of round-leaved wintergreen extract 
 
When studying the effect of the amounts of croscarmellose sodium 
on the disintegration of tablets of round-leaved wintergreen extract, 
it was found that the best disintegration values were obtained in the 
study of croscarmellose sodium at the upper level, and all other 
factors (x1, x2, x4) at the upper star points. When studying the 
amounts of croscarmellose sodium at the lower star points, 
disintegration took the longest time in all cases. 
Therefore, when analyzing the data obtained, it can be concluded 
that all the quality indicators of the tablets meet SPU 
requirements, when the amount of excipients was studied at the 
basic level, only the amount of croscarmellose sodium should be 
stabilized at the upper level to ensure better disintegration of 
tablets. 
As a result of tests performed, based on the analysis of one-factor 
graphic drawings, the optimal composition of tablets of round-
leaved wintergreen extract was determined; all ingredients should 
be taken in the following ratio: dry extract of round-leaved 
wintergreen (0.300 g; 50%), VIVAPUR®112 (0.114 g; 19%), 
PROSOLV® EASYtab SP (0.072 g; 12%), Croscarmellose sodium 
(0.042 g; 7%), Tablettose® 80 (0.042 g; 7%), Neusilin® US 2 (0.024 g; 
4%), Magnesium stearate (0.006 g; 1%). 
In the selection of the best excipients in the development of solid 
dosage forms, different approaches are used [25, 26]. One of the best 
is to use mathematical experiment planning. 
In the study of optimal ethanol concentration and the ratio of 
raw materials to extractant was used regression analysis. The 
alcoholic extract of Centaurium erythraea Rafn. with the highest 
content of hydroxycinnamic acid and phenolic compounds were 
obtained. By which the concentration of the extractant is 69% 
and the optimal ratio of raw material to extractant is 1 to 5 [4].  
Therefore, the regression analysis was successfully used in the 
study of solid dosage forms as well as in the selection of optimal 
excipients. 
CONCLUSION 
The oral solid dosage form with a dry extract of round-leaved 
wintergreen was successfully prepared by the direct compression 
method. The optimal composition of tablets was determiend by the 
regression analysis. Shown successful use of a symmetric, 
rotatable composite plan of the second-order (uniform plan No. 
17) in determining the effect of excipients on the quality of the 
tablets. 
AUTHORS CONTRIBUTIONS 
All the authors have contributed equally 
CONFLICTS OF INTERESTS 
The authors declare no conflict of interest 
REFERENCES 
1. Darzuli N, Vronska L, Groshovyi T, Beley N. Development of 
methods of standardization of medicinal plants–Pyrola 
rotundifolia leaf. Pharma Innov J 2017;6:17-21.  
2. Darzuli N, Denys A, Hroshovyi T. Marketing research of the 
market of drugs and dietary supplements used for the 
treatment of inflammatory diseases of the urinary system. 
Pharm Rev 2017;4:50-6.  
3. Slobodianiuk L, Budniak L, Marchyshyn S, Basaraba R. 
Determination of amino acids and sugars content in Antennaria 
dioica gaertn. Int J Appl Pharm 2019;11:39-43. 
4. Stoiko L, Kurylo K. Development of optimal technology of 
alcohol extract Centaurium erythraea rafn herb. Arch Balk Med 
Union 2018;53:523-8.  
5. Rożycki C, Synoradzki L. Teaching the experimental design. 
Lecture and exercises. Przemyst Chemiczny 2003;8-9:1342-4.  
6. Patwari MAU, Nurul Amin AKM, Faris WF. Prediction of 
tangential cutting force in end milling of medium carbon steel 
by coupling design of experiment and response surface 
methodology. J Mech Eng 2009;40:95–103.  
7. Patel V, Bisoniya TS. Experimental investigation of the effect of 
machining parameters on surface roughness in roller 
burnishing process. Int J Technol Res Engineer 2015;9:2201–4.  
8. Bhagwat Durgacharan A, D’Souza John I. Development of solid 
self micro emulsifying drug delivery system with Neusilin US2 
for enhanced dissolution rate of telmisartan. Int J Drug Dev Res 
2012;4:398-407.  
9. Dias RJ, Mali KK, Ghorpade VS, Havaldar VD, Mohite VR. 
Formulation and evaluation of carbamazepine liquisolid compacts 
using novel carriers. Ind J Pharm Edu Res 2017;51:S69-S78.  
10. Hentzschel CM, Sakmann A, Leopold CS. Suitability of various 
excipients as carrier and coating materials for liquisolid 
compacts. Drug Dev Ind Pharm 2011;37:1200–7.  
11. Aljaberi A, Ardakani A, Khdair A, Abdel-Rahim SA, Meqdadi E, 
Ayyash M, et al. Tableting functionality evaluation of prosolv 
easytab in comparison to physical mixtures of its individual 
components. J Drug Del Sci Tech 2013;23:499–504.  
12. Prosolv EASYtab SP. Product overview. JRS Pharma. Available 
from: https://www.jrspharma.com/pharma_en/products-
services/excipients/hfe/prosolv-easytab-sp.php. [Last 
accessed on 01 Aug 2019]. 
13. Croscarmellose Sodium. Product overview. Available from: 
https://www.roquette.com/pharma-and-nutraceuticals-
croscarmellose-sodium. [Last accessed on 01 Aug 2019] 
14. Tablettose 80. Product overview. Available from: 
https://www.meggle-pharma.com/en/lactose/7-
tablettose80.html. [Last accessed on 01 Aug 2019]  
15. Nelson D, Rebecca W, Wymbs K. Effect of magnesium stearate 
on tablet properties. Available from: 
https://pdfs.semanticscholar.org/ e009/ 
14cd80edbba78a1b9d8643798efb715fa265.pdf. [Last 
accessed on 01 Aug 2019]  
Budniak et al. 
Int J App Pharm, Vol 11, Issue 6, 2019, 210-216 
216 
16. Jilika S, Monika T, Ajay KS, Amit RS. Study of microcrystalline 
cellulose as a substitute of magnesium stearate towards the 
functionality of lubricant in aspirin formulation. Int J Dev Res 
2017;7:15879-84. 
17. Marczynski Z, Zgoda MM, Bodek KH. Extract from Zingiber 
officinale rosc. in solid oral form of a drug. Herba Pol 
2010;56:35-48.  
18. Jaya S, Amala V. Formulation and in vitro evaluation of oral 
disintegrating tablets of amlodipine besylate. Int J Appl Pharm 
2019;11:49-54.  
19. Derzhavna Farmakopeya Ukrayini: v 3 t. Kharkiv: Derzhavne 
pidpriemstvo. Ukrayinskiy naukoviy farmakopeyniy tsentr yakosti 
likarskih zasobiv. State Pharmacopoeia Ukraine 2015;2:1121-5.  
20. Barchuk OZ, Groshovyi TA, Zaliska OM, Shalata VJа. Study of the 
influence of excipients on pharmaco-technological properties 
of tablets based on the extract of bilberry leaves, extract of 
goat’s rue herbs and taurine obtained by direct compression 
method. Pharm Rev 2018;1:47-56. 
21. Maraie NK, Salman ZD, Yousif NZ. Design and characterization 
of or slippery buoyant tablets for ranitidine hydrochloride. 
Asian J Pharm Clin Res 2018;11:143-9. 
22. Patel A, Patel D, Banker K. Effect evaluation of roller 
burnishing process on surface roughness of 6061 T6 A l 
alloy using response surface methodology. Int J Sci Res Dev 
2014;8:142–5.  
23. Suresh PVS, Venkateswara Rao P, Deshmukh SG. A genetic 
algorithmic approach for optimization of surface roughness 
prediction model. Int J Machine Tools Manuf 2002;42:675–
80.  
24. Hroshovyi TA, Martsenyuk VP, Kucherenko LI, Vronska LV, 
Huryeyeva SM. Matematychne planuvannya eksperymentu v 
farmatsiyi [Mathematical planning of experiment in pharmacy]. 
Ternopil, Ukrainian: Ternopil State Medical University; 2008. p. 
304-9. 
25. Marczyński Z, Kowalczykiewicz K, Bodek KH. Selected 
excipients and surfactants in oral solid dosage form with 
extract of Phaseoli pericarpium (Phaseolus vulgaris L.). Herba 
Pol 2015;61:78-92. 
26. Hiremath SP, Makanapur C. Formulation and evaluation of 
orodispersible tablets of a model anti-hypertensive drug. Int J 
Pharm Pharm 2017;9:34-8. 
 
